Metabolomics unveils urinary changes in subjects with metabolic syndrome following 12-week nut consumption - PubMed (original) (raw)
. 2011 Nov 4;10(11):5047-58.
doi: 10.1021/pr200514h. Epub 2011 Sep 29.
Affiliations
- PMID: 21905751
- DOI: 10.1021/pr200514h
Metabolomics unveils urinary changes in subjects with metabolic syndrome following 12-week nut consumption
Sara Tulipani et al. J Proteome Res. 2011.
Abstract
Through an HPLC-Q-TOF-MS-driven nontargeted metabolomics approach, we aimed to discriminate changes in the urinary metabolome of subjects with metabolic syndrome (MetS), following 12 weeks of mixed nuts consumption (30 g/day), compared to sex- and age-matched individuals given a control diet. The urinary metabolome corresponding to the nut-enriched diet clearly clustered in a distinct group, and the multivariate data analysis discriminated relevant mass features in this separation. Metabolites corresponding to the discriminating ions (MS features) were then subjected to multiple tandem mass spectrometry experiments using LC-ITD-FT-MS, to confirm their putative identification. The metabolomics approach revealed 20 potential markers of nut intake, including fatty acid conjugated metabolites, phase II and microbial-derived phenolic metabolites, and serotonin metabolites. An increased excretion of serotonin metabolites was associated for the first time with nut consumption. Additionally, the detection of urinary markers of gut microbial and phase II metabolism of nut polyphenols confirmed the understanding of their bioavailability and bioactivity as a priority area of research in the determination of the health effects derived from nut consumption. The results confirmed how a nontargeted metabolomics strategy may help to access unexplored metabolic pathways impacted by diet, thereby raising prospects for new intervention targets.
Similar articles
- Urolithins are the main urinary microbial-derived phenolic metabolites discriminating a moderate consumption of nuts in free-living subjects with diagnosed metabolic syndrome.
Tulipani S, Urpi-Sarda M, García-Villalba R, Rabassa M, López-Uriarte P, Bulló M, Jáuregui O, Tomás-Barberán F, Salas-Salvadó J, Espín JC, Andrés-Lacueva C. Tulipani S, et al. J Agric Food Chem. 2012 Sep 12;60(36):8930-40. doi: 10.1021/jf301509w. Epub 2012 Jun 5. J Agric Food Chem. 2012. PMID: 22631214 Clinical Trial. - Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome.
López-Uriarte P, Nogués R, Saez G, Bulló M, Romeu M, Masana L, Tormos C, Casas-Agustench P, Salas-Salvadó J. López-Uriarte P, et al. Clin Nutr. 2010 Jun;29(3):373-80. doi: 10.1016/j.clnu.2009.12.008. Epub 2010 Jan 12. Clin Nutr. 2010. PMID: 20064680 Clinical Trial. - Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial.
Mukuddem-Petersen J, Stonehouse Oosthuizen W, Jerling JC, Hanekom SM, White Z. Mukuddem-Petersen J, et al. Br J Nutr. 2007 Jun;97(6):1144-53. doi: 10.1017/S0007114507682944. Epub 2007 Mar 7. Br J Nutr. 2007. PMID: 17381974 Clinical Trial. - Analytical and statistical approaches to metabolomics research.
Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD. Issaq HJ, et al. J Sep Sci. 2009 Jul;32(13):2183-99. doi: 10.1002/jssc.200900152. J Sep Sci. 2009. PMID: 19569098 Review. - A review of the evidence: nuts and body weight.
Natoli S, McCoy P. Natoli S, et al. Asia Pac J Clin Nutr. 2007;16(4):588-97. Asia Pac J Clin Nutr. 2007. PMID: 18042516 Review.
Cited by
- Biomarkers of seaweed intake.
Xi M, Dragsted LO. Xi M, et al. Genes Nutr. 2019 Aug 14;14:24. doi: 10.1186/s12263-019-0648-4. eCollection 2019. Genes Nutr. 2019. PMID: 31428206 Free PMC article. Review. - Fecal Metabolites as Biomarkers for Predicting Food Intake by Healthy Adults.
Shinn LM, Mansharamani A, Baer DJ, Novotny JA, Charron CS, Khan NA, Zhu R, Holscher HD. Shinn LM, et al. J Nutr. 2023 Jan 14;152(12):2956-2965. doi: 10.1093/jn/nxac195. J Nutr. 2023. PMID: 36040343 Free PMC article. - Mediterranean dietary pattern and depression: the PREDIMED randomized trial.
Sánchez-Villegas A, Martínez-González MA, Estruch R, Salas-Salvadó J, Corella D, Covas MI, Arós F, Romaguera D, Gómez-Gracia E, Lapetra J, Pintó X, Martínez JA, Lamuela-Raventós RM, Ros E, Gea A, Wärnberg J, Serra-Majem L. Sánchez-Villegas A, et al. BMC Med. 2013 Sep 20;11:208. doi: 10.1186/1741-7015-11-208. BMC Med. 2013. PMID: 24229349 Free PMC article. Clinical Trial. - Overexpression of vesicle-associated membrane protein PttVAP27-17 as a tool to improve biomass production and the overall saccharification yields in Populus trees.
Gandla ML, Mähler N, Escamez S, Skotare T, Obudulu O, Möller L, Abreu IN, Bygdell J, Hertzberg M, Hvidsten TR, Moritz T, Wingsle G, Trygg J, Tuominen H, Jönsson LJ. Gandla ML, et al. Biotechnol Biofuels. 2021 Feb 16;14(1):43. doi: 10.1186/s13068-021-01895-0. Biotechnol Biofuels. 2021. PMID: 33593413 Free PMC article. - Benefits of Nut Consumption on Insulin Resistance and Cardiovascular Risk Factors: Multiple Potential Mechanisms of Actions.
Kim Y, Keogh JB, Clifton PM. Kim Y, et al. Nutrients. 2017 Nov 22;9(11):1271. doi: 10.3390/nu9111271. Nutrients. 2017. PMID: 29165404 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical